Key points are not available for this paper at this time.
Triple-negative tumors were associated with unique risk factors and worse outcomes compared with HR-positive/HER2-negative tumors.
Share your take
Add a clinician perspective alongside expert commentary.
Lin et al. (2012) studied this question.